We collect and analyze sentiment surrounding ABT stock to help you make informed investment decisions.
Published on November 12, 2024
Abbott Laboratories (NYSE:ABT) has recently garnered attention as it secures a spot on UBS's list of stocks for the AI growth in the low rates era. The company's strong financials have significantly influenced its recent stock performance. As an esta...
Published on November 11, 2024
Abbott Laboratories, a leading pharmaceutical company, has been attracting investor attention recently....
Published on February 28, 2024
QuantWave, the automated forecasting platform, successfully predicted a long position for ABBOTT LABORATORIES on July 22, 2022, with a price of $102.98. The forecast proved accurate as the stock reached the target price of $116.59 on February 28, 202...
Published on February 28, 2024
On July 18, 2023, QuantWave's forecast signal predicted a long position for ABBOTT LABORATORIES stock when it was trading at $102.80. Fast forward to February 28, 2024, the stock successfully reached the forecasted target price of $116.59, resulting ...
Published on February 22, 2024
On July 22, 2022, QuantWave's forecast signal for ABBOTT LABORATORIES indicated a long position with the stock trading at $103.45. Fast forward to February 22, 2024, the predicted target price of $116.11 was achieved, resulting in a profit of 12.24% ...
Published on February 22, 2024
On July 11, 2023, QuantWave issued a forecast signal for ABBOTT LABORATORIES, indicating a long position with a price of $103....
Published on February 22, 2024
On July 18, 2023, QuantWave issued a long signal for ABBOTT LABORATORIES stock when it was priced at 103.26 $....
Published on February 22, 2024
On July 3, 2023, QuantWave, an automated forecasting platform, issued a long signal for ABBOTT LABORATORIES with a price target of 115.59 $. The stock surpassed this target on February 22, 2024, reaching a price of 102.56 $, resulting in a profit of ...
Published on February 22, 2024
On July 11, 2023, QuantWave's forecast signal for ABBOTT LABORATORIES indicated a long position with a price of $102.83....
Published on February 21, 2024
QuantWave, an automated forecasting platform, successfully predicted the price movement of ABBOTT LABORATORIES stock, achieving an 11.61% profit on the forecasted long position. The forecast signal date of July 3, 2023, at a price of $103.02, finally...
Published on February 21, 2024
On June 27, 2023, QuantWave's forecast signal for ABBOTT LABORATORIES indicated a long position at a price of 103.11 $....
Published on February 20, 2024
On June 27, 2023, QuantWave, an automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was priced at 103.57 USD. Fast forward to February 20, 2024, the stock reached the predicted target price of 113.78 USD, result...
Published on January 10, 2024
On December 5, 2023, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock, which was trading at $100.85 at the time. The prediction proved to be accurate as on January 10, 2024, the stock reached the forec...
Published on October 12, 2023
QuantWave, a leading automated forecasting platform, has successfully achieved its price target forecast for ABBOTT LABORATORIES stock. The forecast signal was issued on April 4, 2023, with the stock price at 98.29 $ and the predicted direction of sh...
Published on October 12, 2023
Abbott Laboratories (NYSE: ABT) recently achieved the forecast price target set by QuantWave, signaling a profitable short position for investors. The forecast signal was issued on April 4, 2023, with the stock priced at 97.85 $. The predicted direct...
Published on April 19, 2023
QuantWave, a leading automated forecasting platform, achieved another successful prediction as the stock of ABBOTT LABORATORIES reached its forecasted price target on April 19, 2023. The forecast signal was generated on February 21, 2023, with a pric...